Maurie Markman,


President of Medicine & Science, City of Hope Atlanta, Chicago and Phoenix

Maurie Markman - Board Member and President, Medicine & Science

From the beginning of my career, I recognized the importance of practicing medicine as a 'people’s doctor.'

Medical Oncology
Medical school:
New York University School of Medicine
Residency, Internal Medicine - New York University Medical Center Bellevue Hospital
Hematology and Oncology – National Cancer Institute, Rockville, MD
Hematology and Oncology – Johns Hopkins University (Sidney Kimmel Comprehensive Cancer Center), Baltimore, MD
Advanced degrees:
Graduate Certificate, Advanced Study in Bioethics – Cleveland State University, Cleveland, OH 
MS, Health Policy & Management – New York University Graduate School of Public Administration, New York, NY
Diplomate, American Board of Internal Medicine
Medical Oncology, Hematology and Internal Medicine – American Board of Internal Medicine
About Me

Early in his career, a mentor reminded Dr. Maurie Markman to approach the practice of medicine as a “people’s doctor.” This advice resonated with Dr. Markman, and he continues to carry it with him as he treats patients today.

Dr. Markman, an American Board of Internal Medicine (ABIM) Diplomate who is ABIM board-certified in medical oncology, hematology and internal medicine, joined City of Hope in September 2010. He says he was drawn to City of Hope by its patient-centered approach to cancer care and philosophy of treating the whole person, not just the disease. A nationally renowned oncologist, Dr. Markman is President of Medicine & Science at City of Hope. Previously, he was Senior Vice President of Clinical Affairs and National Director of Medical Oncology.

“From the beginning of my career, I recognized the importance of practicing medicine as a ‘people’s’ doctor,’” says Dr. Markman. “All of my research and work has been motivated by the thought of giving patients every option to beat their disease.”

Dr. Markman has decades of experience in cancer treatment and gynecologic research at some of the country’s most recognized facilities.

In June 2011, he received the esteemed American Society of Clinical Oncology (ASCO) Statesman Award. Presented annually, the Statesman Award recognizes individual ASCO members who have shown extraordinary volunteer service, dedication and commitment to ASCO, their hospital community and the patients they serve for at least 20 years.

Most recently, Dr. Markman served as the Vice President for Clinical Research and Chairman of the Department of Gynecologic Medical Oncology at M.D. Anderson Cancer Center in Houston, Texas, where he also served as a Professor of Medicine.

Prior to that, Dr. Markman spent 11 years as Chairman of the Department of Hematology/Oncology and Director of the Taussig Cancer Center at the Cleveland Clinic Foundation. He also spent five years as Vice Chairman of the Department of Medicine at Memorial Sloan-Kettering Cancer Center in New York.

A Diplomate of the American Board of Internal Medicine, Dr. Markman is board certified in internal medicine, medical oncology and hematology. He also holds a Graduate Certificate of Advanced Study in Bioethics from the Department of Philosophy at Cleveland State University.

Dr. Markman began his undergraduate education at the University of Southern California, where he earned a bachelor’s degree in Biology and graduated summa cum laude. He went on to earn a medical degree from New York University School of Medicine.

Following medical school, Dr. Markman completed an internship and residency in internal medicine at Bellevue Hospital-New York University Medical Center, where he was named Chief Resident in his final year. He then completed fellowship training in hematology and oncology at both the National Cancer Institute and Johns Hopkins University (Sidney Kimmel Comprehensive Cancer Center) in Maryland.

Dr. Markman also holds a master’s degree in health policy and management from New York University Graduate School of Public Administration.

Dedicated to finding new and innovative ways to treat cancer, Dr. Markman has published more than 1400 articles, editorials, peer-reviewed manuscripts, book chapters, reviews, letters and abstracts.

Dr. Markman has written or co-edited 10 books and served as an editorial board member on over 40 journals. He is currently Editor-in-Chief of numerous oncology journals, including Oncology Digest and Current Oncology Reports. He is also a Fellow of the American College of Physicians and the American Society of Clinical Oncology.

Dr. Markman is regularly listed as one of the “Best Doctors in America” by Best Doctors, Inc., one of “America’s Top Doctors” by Castle Connelly Medical Ltd., and one of “America’s Top Oncologists” by Consumer’s Research Council of America. In 1999 he was recognized as the Lee and Jerome Burkons Research Chair in Oncology by the Cleveland Clinic.

He is widely regarded for his knowledge and expertise as a practicing clinical oncologist and is frequently asked to be a visiting professor and guest lecturer at universities and medical schools across the country. He has served as a member of hundreds of national and regional oncology committees.

Dr. Markman is a member of numerous professional organizations, including, but not limited to: the American College of Physicians, the American Society of Clinical Oncology, the American Association for Cancer Research, the American Society of Hematology and the Society of Gynecologic Oncology.
Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.